meturedepa has been researched along with Carcinoma, Bronchogenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AMBRUS, JL; ROSS, CA; SOKAL, JE; STUTZMAN, L; VELASCO, HA; WEBSTER, JH | 1 |
| KOLAR, V; KONECNY, M; MECHL, Z | 1 |
| Ambrus, CM; Ambrus, JL; Bardos, TJ; Chmielewicz, ZF | 1 |
1 trial(s) available for meturedepa and Carcinoma, Bronchogenic
| Article | Year |
|---|---|
Radiation sensitizing agents in clinical radiation and chemotherapy.
Topics: Aziridines; Azirines; Carcinoma, Bronchogenic; Child; Clinical Trials as Topic; Female; Humans; Lung Neoplasms; Male; Neoplasms; Palliative Care; Radiation-Sensitizing Agents; Random Allocation | 1980 |
2 other study(ies) available for meturedepa and Carcinoma, Bronchogenic
| Article | Year |
|---|---|
COMBINED USE OF AB-132 (METUREDEPA, TURLOC) AND X-IRRADIATION IN THE MANAGEMENT OF ADVANCED BRONCHOGENIC CARCINOMA.
Topics: Alkylating Agents; Antineoplastic Agents; Aziridines; Biomedical Research; Carbamates; Carcinoma, Bronchogenic; Leukopenia; Neoplasms; Pathology; Thrombocytopenia; Toxicology | 1964 |
THE USE OF THE DRUGS AB 103 AND AB 132 IN THE COMBINED TREATMENT OF TUMOURS OF THE CERVICAL AND PULMONARY REGIONS.
Topics: Alkylating Agents; Antineoplastic Agents; Aziridines; Carbamates; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Geriatrics; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Maxillary Neoplasms; Neoplasms; Parotid Neoplasms; Pharyngeal Neoplasms; Sarcoma; Tongue Neoplasms | 1964 |